United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

5:36pm GMT
Change (% chg)

$-0.03 (-4.63%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

John Sedor

73 2016 Chairman of the Board, Chief Executive Officer

Angus Smith

35 2018 Senior Vice President, Chief Business Officer and Principal Financial Officer

Kenneth Pina

59 2017 Senior Vice President, Chief Legal and Compliance Officer and Corporate Secretary

Glenn Whaley

50 2018 Principal Accounting Officer, Vice President - Finance, Controller

John Leone

70 2018 Lead Independent Director